Publicaciones en colaboración con investigadores/as de Hospital General Universitario Reina Sofía (69)

2023

  1. Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases

    International Journal of Molecular Sciences, Vol. 24, Núm. 22

2022

  1. Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients

    Cancers, Vol. 14, Núm. 13

2018

  1. Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA 2 DS 2 -VASc and HAS-BLED scores using multiple biomarkers

    Annals of Medicine, Vol. 50, Núm. 1, pp. 26-34

  2. Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency

    Thrombosis Research, Vol. 163, pp. 64-70

2017

  1. High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study

    Haemophilia, Vol. 23, Núm. 6, pp. e488-e496

  2. Prognostic value of computed tomography pulmonary angiography indices in patients with cancer-related pulmonary embolism: Data from a multicenter cohort study

    European Journal of Radiology, Vol. 87, pp. 66-75

2013

  1. Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms

    Oncologist, Vol. 18, Núm. 4, pp. 446-453

2012

  1. Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation

    International Journal of Cardiology, Vol. 154, Núm. 3, pp. 282-286

2011

  1. Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica

    Gaceta Sanitaria, Vol. 25, Núm. 4, pp. 274-281

  2. Fe de errores de "Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica"

    Gaceta Sanitaria

2006

  1. Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients

    Stroke, Vol. 37, Núm. 9, pp. 2288-2293

2004

  1. Genetic variants of the extra-large stimulatory Gs protein alpha-subunit and risk of thrombotic and haemorrhagic disorders

    British Journal of Haematology, Vol. 125, Núm. 5, pp. 621-628

  2. Platelet GP IIIa polymorphism HPA-1 (PlA) protects against subarachnoid hemorrhage

    Stroke, Vol. 35, Núm. 10, pp. 2282-2286

2003

  1. Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: New application for a classical method

    Journal of Laboratory and Clinical Medicine, Vol. 142, Núm. 5, pp. 298-305

  2. Polymorphisms of platelet adhesive receptors: Do they play a role in primary intracerebral hemorrhage?

    Cerebrovascular Diseases, Vol. 15, Núm. 1-2, pp. 51-55

2002

  1. A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

    Blood, Vol. 100, Núm. 6, pp. 2081-2086

  2. Prothrombin A19911G and G20210A polymorphisms' role in thrombosis

    British Journal of Haematology, Vol. 118, Núm. 2, pp. 610-614

2001

  1. Administration of post-autologous PBSCT rhG-CSF is associated with long-term low concentrations of bone marrow hematopoietic progenitor cells

    Bone Marrow Transplantation, Vol. 27, Núm. 12, pp. 1287-1292

  2. Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation

    European Journal of Haematology, Vol. 66, Núm. 2, pp. 130-132

  3. Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease

    British Journal of Haematology, Vol. 115, Núm. 4, pp. 969-976